Method of producing antibody-fortified dry whey

• US 5,017,372 A
• Filed: 10/19/1988
• Issued: 05/21/1991
• Est. Priority Date: 04/14/1986
• Status: Expired due to Fees

• Current Assignee: Donald H. Hastings
• Original Assignee: Medicis Corporation
• Inventors: Hastings, Donald H.
• Primary Examiner(s): Schain, Howard E.
• Application Number:
  US07/259,735
• Time in Patent Office: 944 Days
• Field of Search: 424/87, 424/85.8, 530/833, 530/387, 514/54
• US Class Current: 424/157.1
• CPC Class Codes: A23C 21/00 Whey; Whey preparations concentration, evaporation or drying A23C1/00; preservation of milk or milk preparations A23C3/00; milk preparations, milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment A23C9/14
• CPC Class Codes: C07K 16/04 from milk
• CPC Class Codes: C07K 16/1232 from Escherichia (G)
• CPC Class Codes: Y10S 530/833 Whey; cheese

Abstract

A method of producing a dry whey protein powder fortified with naturally occurring polyclonal antibody IgG to preselected infectious intestinal disease antigens, primarily diarrhea-causing enterotoxigenic Escherichia coli bacteria bearing colonization factor antigens (CFA) I or II and heat labile toxins. The product is made by first immunizing a pregnant ungulate, such as a cow, by administration of antigens of the preselected disease. After parturition the milk from the ungulate is collected and maintained in its natural state. The milk is subjected to a standard cheese-making process which produces coagulated casein and whey. The antibody IgG is carried into the whey, which is concentrated and dried. The resulting dried protein powder contains the antibody. The product may be administered orally to living beings, both humans and other animals, to prevent contraction of the preselected disease and to treat bodies exposed to the disease.

Claims

1. A dry whey protein powder fortified with polyclonal antibodies against preselected infectious intestinal disease antigens made according to a method comprising the steps of:

a. immunizing a pregnant ungulate by administration to the ungulate of the preselected infectious intestinal disease antigens in a non-pathogenic condition;

b. collecting and maintaining the milk from the ungulate after parturition, the milk containing a higher than normal concentration of antibodies against the preselected infectious intestinal disease antigens because of the immunization step;

c. producing unfractionated whey fortified with naturally occurring polyclonal antibodies against the preselected infectious intestinal disease antigens from the milk by removing milk casein; and

d. concentrating and drying the unfractionated whey to produce a whey protein powder fortified with naturally occurring polyclonal antibodies against the preselected infectious intestinal disease antigens.

2. The dry whey protein powder of claim 1, wherein the preselected infectious intestinal disease antigen is derived from a diarrhea-causing enterotoxigenic Escherichia coli bacteria bearing at least one of the colonization factor antigens and heat labile toxins.

15. The dry whey protein powder of claim 1, wherein the whey is produced by treating the milk with starter-rennet.

16. The dry whey protein powder of claim 1, wherein the whey is produced by acidification of the milk.

3. A method of preventing an intestinal disease in a human or animal comprising prophylactically administering to the human or animal an effective oral dose of a dry whey powder fortified with polyclonal antibodies against antigens associated with the intestinal disease made according to a method comprising the steps of:

a. immunizing a pregnant ungulate by administration to the ungulate the antigens associated with the intestinal disease in a non-pathogenic condition;

b. collecting and maintaining the milk from the ungulate after parturition, the milk containing a higher than normal concentration of polyclonal antibodies against antigens associated with the intestinal disease because of the immunization step;

c. producing unfractionated whey fortified with naturally occurring polyclonal antibodies against the intestinal disease antigens from the milk by removing milk casein; and

d. concentrating and drying the unfractionated whey to produce a whey protein powder fortified with naturally occurring polyclonal antibodies against the intestinal disease antigens.

4. The method of claim 3, wherein the dry whey powder is mixed with a beverage before administration to the human or animal.

5. The method of claim 3, wherein the dry whey powder is incorporated into a food bar.

6. The method claim 3, wherein the preselected infectious intestinal disease antigen is derived from a diarrhea-causing enterotoxigenic Escherichia coli bacteria bearing at least one of the colonization factor antigens and heat labile toxins.

7. The method of claim 6, wherein the dry whey powder is admixed with a beverage before administration to the human or animal.

8. The method of claim 6, wherein the dry whey powder is incorporated into a food bar.

17. The dry whey protein powder of claim 3, wherein the whey is produced by treating the milk with starter-rennet.

18. The dry whey protein powder of claim 3, wherein the whey is produced by acidification of the milk.

9. A method of treating an intestinal disease in a human or animal comprising administering to the human or animal with the intestinal disease an effective oral dose of a dry whey powder fortified with polyclonal antibodies against antigens associated with the intestinal disease made according to a method comprising the steps of:

a. immunizing a pregnant ungulate by administration to the ungulate the antigens associated with the intestinal disease in a non-pathogenic condition;

b. collecting and maintaining the milk from the ungulate after parturition, the milk containing a higher than normal concentration of polyclonal antibodies against antigens associated with the intestinal disease because of the immunization step;

c. producing unfractionated whey fortified with naturally occurring polyclonal antibodies against the intestinal disease antigens from the milk by removing milk casein; and

d. concentrating and drying the unfractionated whey to produce a whey protein powder fortified with naturally occurring polyclonal antibodies against the intestinal disease antigens.

10. The method of claim 9, wherein the dry whey powder is admixed with a beverage before administration to the human or animal.

11. The method of claim 9, wherein the dry whey powder is incorporated into a food bar.

12. The method of claim 9, wherein the preselected infectious intestinal disease antigen is derived from a diarrhea-causing enterotoxigenic Escherichia coli bacteria bearing at least one of the colonization factor antigens and heat labile toxins.

13. The method of claim 12, wherein the dry whey powder is admixed with a beverage before administration to the human or animal.

14. The method of claim 12, wherein the dry whey powder is incorporated into a food bar.

19. The dry whey protein powder of claim 9, wherein the whey is produced by treating the milk with starter-rennet.

20. The dry whey protein powder of claim 9, wherein the whey is produced by acidification of the milk.